HIV Testing and Diagnosis Rates in Kiev, Ukraine: April 2013-March 2014

Data from Ukraine on risk factors for HIV acquisition are limited. We describe the characteristics of individuals testing for HIV in the main testing centres of the Ukrainian capital Kiev, including HIV risk factors, testing rates, and positivity rates. As part of a larger study to estimate HIV incidence within Kiev City, we included questions on possible risk factors for HIV acquisition and testing history to existing systems in 4 infectious disease clinics. Data were provided by the person requesting an HIV test using a handheld electronic tablet. All persons (≥16 yrs) presenting for an HIV test April 2013-March 2014 were included. Rates per 100,000 were calculated using region-specific denominators for Kiev. During the study period 6370 individuals tested for HIV, equivalent to a testing rate of 293.2 per 100,000. Of these, 467 (7.8%) were HIV-positive, with the highest proportion positive among 31-35 year olds (11.2%), males (9.4%), people who inject drugs (PWID) (17.9%) and men who have sex with men (MSM) (24.1%). Using published population size estimates of MSM, diagnosis rates for MSM ranged from 490.6 to 1548.3/100,000. A higher proportion of heterosexual women compared to heterosexual men reported contact with PWID, (16% vs. 4.7%) suggesting a bridging in risk between PWID and their sexual partners. Collection of HIV risk factor information in Kiev, essential for the purposes of developing effective HIV prevention and response tools, is feasible. The high percentage of MSM among those testing positive for HIV, may indicate a significant level of undisclosed sex between men in national figures

HIV Testing and Diagnosis Rates in Kiev, Ukraine: April 2013-March 2014

Data from Ukraine on risk factors for HIV acquisition are limited. We describe the characteristics of individuals testing for HIV in the main testing centres of the Ukrainian capital Kiev, including HIV risk factors, testing rates, and positivity rates. As part of a larger study to estimate HIV incidence within Kiev City, we included questions on possible risk factors for HIV acquisition and testing history to existing systems in 4 infectious disease clinics. Data were provided by the person requesting an HIV test using a handheld electronic tablet. All persons (≥16 yrs) presenting for an HIV test April 2013-March 2014 were included. Rates per 100,000 were calculated using region-specific denominators for Kiev. During the study period 6370 individuals tested for HIV, equivalent to a testing rate of 293.2 per 100,000. Of these, 467 (7.8%) were HIV-positive, with the highest proportion positive among 31-35 year olds (11.2%), males (9.4%), people who inject drugs (PWID) (17.9%) and men who have sex with men (MSM) (24.1%). Using published population size estimates of MSM, diagnosis rates for MSM ranged from 490.6 to 1548.3/100,000. A higher proportion of heterosexual women compared to heterosexual men reported contact with PWID, (16% vs. 4.7%) suggesting a bridging in risk between PWID and their sexual partners. Collection of HIV risk factor information in Kiev, essential for the purposes of developing effective HIV prevention and response tools, is feasible. The high percentage of MSM among those testing positive for HIV, may indicate a significant level of undisclosed sex between men in national figures

Distribution of all persons testing for HIV and persons newly diagnosed at any one of the four HIV testing sites between April 2013 –March 2014 in Kiev City, Ukraine.

<p>* Persons with more than one reported risk factor were classified by the following hierarchical order: PWID, MSM, then heterosexual contact. Persons with more than one reported reason for test were classified by the following hierarchical order: general Screening, clinical indication, then high risk population.</p><p>^<b>≠</b> Excluding 32 persons: 7 records were missing year of birth, sex or identification number, and 25 persons were already known to be HIV positive.</p><p>Distribution of all persons testing for HIV and persons newly diagnosed at any one of the four HIV testing sites between April 2013 –March 2014 in Kiev City, Ukraine.</p

Factors associated with repeat testing among persons attending for an HIV test April 2013– March 2014 in Kiev City, Ukraine.

<p>* Adjusted for all other factors in table.</p><p>Factors associated with repeat testing among persons attending for an HIV test April 2013– March 2014 in Kiev City, Ukraine.</p

HIV testing and diagnosis rates (per 100,000 population) for persons seeking testing April 2013– March 2014 in Kiev City, Ukraine.

<p>* Excluding 32 persons: 7 records were missing year of birth, sex or identification number, and 25 persons were already known to be HIV positive.</p><p>HIV testing and diagnosis rates (per 100,000 population) for persons seeking testing April 2013– March 2014 in Kiev City, Ukraine.</p

Factors association with testing recent according to the LAg assay in Kiev City, Ukraine: April 2013 –March 2014

<p>Factors association with testing recent according to the LAg assay in Kiev City, Ukraine: April 2013 –March 2014</p

Characteristics of persons newly diagnosed with HIV and the proportion identified as recently infected using the LAg Avidity EIA, Kiev City, Ukraine: April 2013 –March 2014.

<p>Characteristics of persons newly diagnosed with HIV and the proportion identified as recently infected using the LAg Avidity EIA, Kiev City, Ukraine: April 2013 –March 2014.</p

HIV incidence estimates using the limiting antigen avidity EIA assay at testing sites in Kiev City, Ukraine: 2013-2014

Objective: To estimate HIV incidence and highlight the characteristics of persons at greatest risk of HIV in the Ukraine capital, Kiev. Method: Residual samples from newly-diagnosed persons attending the Kiev City AIDS Centre were tested for evidence of recent HIV infection using an avidity assay. Questions on possible risk factors for HIV acquisition and testing history were introduced. All persons (≥16yrs) presenting for an HIV test April'13-March'14 were included. Rates per 100,000 population were calculated using region-specific denominators. Results: During the study period 6370 individuals tested for HIV. Of the 467 individuals newly-diagnosed with HIV, 21 had insufficient samples for LAg testing. Of the remaining 446, 39 (8.7%) were classified as recent with an avidity index <1.5ODn, 10 were reclassified as long-standing as their viral load was <1000 copies/mL, resulting in 29 (6.5%) recent HIV infections. The only independent predictor for a recent infection was probable route of exposure, with MSM more likely to present with a recent infection compared with heterosexual contact [Odds Ratio 8.86; 95%CI 2.65-29.60]. We estimated HIV incidence at 21.5 per 100,000 population, corresponding to 466 new infections. Using population estimates for MSM and PWID, incidence was estimated to be between 2289.6 and 6868.7/100,000 MSM, and 350.4 for PWID. Conclusion: A high proportion of persons newly-infected remain undiagnosed, with MSM disproportionally affected with one in four newly-HIV-diagnosed and one in three recently-HIV-infected. Our findings should be used for targeted public health interventions and health promotion